JOSHUA COLEMAN was named vice president of medical affairs at GenomOncology. He will oversee clinical content development and curation of scientific evidence, enhancing the company’s proprietary knowledge-enabled platform. The GenomOncology software suite empowers molecular pathologists with a seamless workflow for the interpretation of genetic sequencing data and clinical decision support, from quality control through reporting. […]
TEMPUS, a technology company focused on supporting physicians delivering customized cancer care, and the University of Pennsylvania Abramson Cancer Center partnered to better determine which patients will have a positive response to immunotherapy treatment based on next generation genomic and transcriptomic sequencing. As part of a research collaboration, Tempus will provide sequencing and analysis of […]
MICHAEL ZINNER was elected chair of the Board of Regents of the American College of Surgeons. Zinner is a general surgeon with expertise in pancreatic-hepatobiliary diseases. Since 2016, he has been the founding chief executive officer and executive medical director of the Miami Cancer Institute–Baptist Health South Florida. Prior to that time, he served as […]
William Oh was named deputy director of The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.
Peter Pisters started Dec. 1, his first day as president of MD Anderson Cancer Center, by launching a listening tour.
Viviane Tabar was named chair of the department of neurosurgery at Memorial Sloan Kettering Cancer Center.
Aradhana Ghosh has joined Syapse as vice president of oncology.
Ponce Health Sciences University of Ponce, Puerto Rico, in partnership with the H. Lee Moffitt Cancer Center has received a type U54 grant of $16 million from NCI.
Western Connecticut Health Network has launched a $2.7 million, three-year research study to investigate the link between new-onset diabetes and pancreatic cancer.
Sundar Jagannath, director of the Multiple Myeloma Program at the Icahn School of Medicine at Mount Sinai, received the 2017 Innovator Award from the Multiple Myeloma Research Consortium/Multiple Myeloma Research Foundation.
